- Home
- LNTH vs KBR Comparison
LNTH vs KBR Comparison
Compare LNTH & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- KBR
- Stock Information
- Founded
- LNTH 1956
- KBR 1901
- Country
- LNTH United States
- KBR United States
- Employees
- LNTH N/A
- KBR N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- KBR Military/Government/Technical
- Sector
- LNTH Health Care
- KBR Industrials
- Exchange
- LNTH Nasdaq
- KBR Nasdaq
- Market Cap
- LNTH 7.2B
- KBR 7.8B
- IPO Year
- LNTH 2015
- KBR 2006
- Fundamental
- Price
- LNTH $90.52
- KBR $61.76
- Analyst Decision
- LNTH Strong Buy
- KBR Strong Buy
- Analyst Count
- LNTH 7
- KBR 8
- Target Price
- LNTH $121.86
- KBR $81.00
- AVG Volume (30 Days)
- LNTH 1.6M
- KBR 2.0M
- Earning Date
- LNTH 11-06-2024
- KBR 10-23-2024
- Dividend Yield
- LNTH N/A
- KBR 0.97%
- EPS Growth
- LNTH 304.57
- KBR N/A
- EPS
- LNTH 6.02
- KBR 2.39
- Revenue
- LNTH $1,496,799,000.00
- KBR $7,350,000,000.00
- Revenue This Year
- LNTH $19.56
- KBR $10.78
- Revenue Next Year
- LNTH $6.32
- KBR $16.22
- P/E Ratio
- LNTH $15.03
- KBR $25.89
- Revenue Growth
- LNTH 24.15
- KBR 7.55
- 52 Week Low
- LNTH $50.20
- KBR $50.45
- 52 Week High
- LNTH $126.89
- KBR $72.60
- Technical
- Relative Strength Index (RSI)
- LNTH 45.56
- KBR 40.49
- Support Level
- LNTH $75.00
- KBR $57.13
- Resistance Level
- LNTH $118.21
- KBR $59.15
- Average True Range (ATR)
- LNTH 5.13
- KBR 2.25
- MACD
- LNTH 0.13
- KBR -0.94
- Stochastic Oscillator
- LNTH 38.71
- KBR 30.08
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About KBR KBR Inc.
KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7 billion in revenue in 2023.